Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Ulm |
---|---|
Information provided by: | University of Ulm |
ClinicalTrials.gov Identifier: | NCT00151255 |
This is a study looking at all-trans retinoic acid in combination with standard induction and consolidation therapy in older patients with newly diagnosed acute myeloid leukemia (AML).
Condition | Intervention | Phase |
---|---|---|
Acute Myeloid Leukemia |
Drug: Cytarabine Drug: Idarubicin Drug: All-trans retinoic acid Drug: Mitoxantrone Drug: Etoposid |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Phase III - Study on All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia |
Estimated Enrollment: | 500 |
Study Start Date: | June 2004 |
Estimated Study Completion Date: | October 2010 |
Estimated Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |
First Induction Therapy:
Idarubicin 12 mg/m² i.v. days 1, 3
Second Induction Therapy:
Idarubicin 12 mg/m² i.v. days 1, 3
First Consolidation Therapy:
Mitoxantrone 10 mg/m² i.v. days 2, 3
Second Consolidation Therapy
Idarubicin 12 mg/m² i.v. days 1,3
Ages Eligible for Study: | 61 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Austria | |
Department of Hematology/Oncology, University Hospital of Innsbruck | |
Innsbruck, Austria, 6020 | |
Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern | |
Linz, Austria, 4010 | |
Medical Department III, St. Johann Hospital | |
Salzburg, Austria, 5020 | |
Center of hematology and oncology, Hanusch Hospital | |
Wien, Austria, 1140 | |
Germany | |
Department of General Internal Medicine, University Hospital of Bonn | |
Bonn, Germany, 53127 | |
Department of Hematology and Oncology, Hospital Essen-Süd, Ev. Hospital of Essen-Werden | |
Essen, Germany, 45239 | |
Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst | |
Frankfurt, Germany, 65929 | |
Medical Department IV, University Hospital of Giessen | |
Giessen, Germany, 35392 | |
Department of Internal Medicine, Wilhelm-Anton Hospital gGmbH | |
Goch, Germany, 47574 | |
Centre of Internal Medicine, University Hospital of Göttingen | |
Göttingen, Germany, 37075 | |
Department of Oncology and Hematology, University Hospital Eppendorf | |
Hamburg, Germany, 20246 | |
Department of Internal Medicine I, University Hospital of Saarland | |
Homburg, Germany, 66421 | |
Medical Department II, City Hospital Karlsruhe gGmbH | |
Karlsruhe, Germany, 76133 | |
Medical Department II, University Hospital of Kiel | |
Kiel, Germany, 24116 | |
Medical Department II, Diakonie Hospital | |
Stuttgart, Germany, 70176 | |
Department of Hematology/Oncology, Clinical Center of Lüdenscheid | |
Lüdenscheid, Germany, 58515 | |
Medical Department III, Clinical Center Rechts der Isar | |
München, Germany, 81675 | |
Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH | |
Oldenburg, Germany, 26133 | |
Department of Hematology and Oncology/Caritas Hospital St. Theresa | |
Saarbrücken, Germany, 66113 | |
Department of Oncology, Clinical Center of Stuttgart | |
Stuttgart, Germany, 70174 | |
I. Medical Department, Hospital of Barmerzigen Brüder | |
Trier, Germany, 54292 | |
Medical Center II - Hematology/Oncology, Clinical Center Villingen-Schwenningen | |
Villingen - Schwenningen, Germany, 78050 | |
Medical Department I, Helios Hospital Wuppertal | |
Wuppertal, Germany, 42283 | |
Department of Internal Medicine I, Central Hospital of Augsburg | |
Augsburg, Germany, 86856 | |
Medical Department I, Hospital of Bremen-Mitte | |
Bremen, Germany, 28177 | |
Medical Department II, General Hospital Altona | |
Hamburg, Germany, 22763 | |
Medical Department III, Hospital of Hanau | |
Hanau, Germany, 63450 | |
Medical Department III, Hospital of Hannover-Siloah | |
Hannover, Germany, 30449 | |
Department of Internal Medicine/Hematology and Oncology, Caritas Hospital Lebach | |
Lebach, Germany, 66822 |
Principal Investigator: | Richard F Schlenk, Dr. | Department of Internal Medicine III, University of Ulm |
Responsible Party: | University of Ulm ( Prof. Dr. Reinhard Marre ) |
Study ID Numbers: | AMLSG06-04 |
Study First Received: | September 6, 2005 |
Last Updated: | October 1, 2008 |
ClinicalTrials.gov Identifier: | NCT00151255 |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
age > 60 years |
Leukemia Idarubicin Acute myelogenous leukemia Tretinoin Mitoxantrone |
Leukemia, Myeloid Leukemia, Myeloid, Acute Acute myelocytic leukemia Cytarabine |
Antimetabolites Anti-Infective Agents Neoplasms by Histologic Type Antimetabolites, Antineoplastic Molecular Mechanisms of Pharmacological Action Immunologic Factors Antineoplastic Agents Physiological Effects of Drugs Antibiotics, Antineoplastic Antiviral Agents |
Immunosuppressive Agents Pharmacologic Actions Keratolytic Agents Neoplasms Sensory System Agents Therapeutic Uses Peripheral Nervous System Agents Analgesics Dermatologic Agents Central Nervous System Agents |